Showing results (451-460 of 1,291) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|November 8, 2014
Is there new hope for therapeutic matrix metalloproteinase inhibition?Roosmarijn E Vandenbroucke, Claude LibertNature Reviews. Drug Discovery|November 1, 2014
The Critical Path Institute: transforming competitors into collaboratorsMartha BrumfieldNature Reviews. Drug Discovery|November 1, 2014
The predictive safety testing consortium and the coalition against major diseasesDiane Stephenson, John-Michael SauerNature Reviews. Drug Discovery|November 1, 2014
The international serious adverse events consortiumArthur L Holden, Jorge L Contreras, Sally John, et al.Nature Reviews. Drug Discovery|November 15, 2014
SCF ubiquitin ligase-targeted therapiesJeffrey R Skaar, Julia K Pagan, Michele PaganoNature Reviews. Drug Discovery|December 6, 2019
Rethinking drug design in the artificial intelligence eraPetra Schneider, W Patrick Walters, Alleyn T Plowright, et al.Nature Reviews. Drug Discovery|February 29, 2020
Antimicrobial host defence peptides: functions and clinical potentialNeeloffer Mookherjee, Marilyn A Anderson, Henk P Haagsman, et al.Nature Reviews. Drug Discovery|January 26, 2019
Interferons α and β in cancer: therapeutic opportunities from new insightsErnest C BordenNature Reviews. Drug Discovery|February 16, 2020
Next-generation influenza vaccines: opportunities and challengesChih-Jen Wei, Michelle C Crank, John Shiver, et al.Nature Reviews. Drug Discovery|January 16, 2020
Publisher Correction: Breast cancer drug approvals by the US FDA from 1949 to 2018Chandra P Leo, Cornelia Leo, Thomas D SzucsPageof 130